This federal contract award is for the delivery of Valsartan-HCTZ 320-25 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $9,941.69, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order with a firm fixed price and an ultimate completion date of February 28, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The federal contract award is for the delivery of Valsartan-HCTZ 320-25 mg tablets to support the medical supply chain needs of the Defense Logistics Agency (DLA) Troop Support Medical. The $44,649.27 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 25, 2024 and was awarded on January 24, 2024. The award is not designated as a set-aside....
This federal contract award is for the delivery of Valsartan-HCTZ 320-25 mg tablets in 90-count packages to the Defense Logistics Agency (DLA). The $4,626.40 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical worth up to $999,999,999 through December 2025. This IDC enables DLA to efficiently procure a wide range of essential medical commodities,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,018.59 firm-fixed-price delivery order is for the supply of Valsartan-HCTZ 320-25 mg tablets in 90-count bottles. The contract has an ultimate completion date of August 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award, valued at $4,296.28, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, issued by the Defense Logistics Agency (DLA), is a delivery order that provides the federal government with Valsartan-HCTZ 320-25 mg tablets. The contract has a firm fixed price and an ultimate completion date of June 26, 2024. This award is not associated with a set-aside designation, indicating open competition....
This federal contract award is for the delivery of Valsartan-HCTZ 320-25 mg tablets, supplied by Amerisourcebergen Drug Corp's Corporate Office division to the Defense Logistics Agency (DLA). The contract, valued at $1,433.39, is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to deliver a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $9,312.55 firm fixed-price delivery order is for the supply of Valsartan-HCTZ 80-12.5 mg tablets. The contract has an ultimate completion date of August 13, 2024 and does not utilize a set-aside. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which...
This federal contract award is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $9,340.11 and is a firm fixed-price delivery order with a completion date of February 5, 2024. This contract is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $2,643.83, is for the delivery of Valsartan-HCTZ 320-12.5 mg tablets in 90-count bottles. The contract has an ultimate completion date of February 23, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., the parent company. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,424.26 firm fixed-price delivery order is for the supply of Valsartan-HCTZ 320-25 mg tablets. The contract has an ultimate completion date of February 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...